These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10652609)

  • 1. CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.
    Coventry BJ
    Anticancer Res; 1999; 19(4B):3183-7. PubMed ID: 10652609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours.
    Hillenbrand EE; Neville AM; Coventry BJ
    Br J Cancer; 1999 Feb; 79(5-6):940-4. PubMed ID: 10070894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenously expressed HIV-1 nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells.
    Shinya E; Owaki A; Shimizu M; Takeuchi J; Kawashima T; Hidaka C; Satomi M; Watari E; Sugita M; Takahashi H
    Virology; 2004 Aug; 326(1):79-89. PubMed ID: 15262497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization.
    Sandel MH; Dadabayev AR; Menon AG; Morreau H; Melief CJ; Offringa R; van der Burg SH; Janssen-van Rhijn CM; Ensink NG; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Clin Cancer Res; 2005 Apr; 11(7):2576-82. PubMed ID: 15814636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines.
    Serhal K; Baillou C; Ghinea N; Fontanges P; Dupuy FP; Lemoine FM; Lacave R
    Int J Oncol; 2007 Dec; 31(6):1357-65. PubMed ID: 17982663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1c molecules broadly survey the endocytic system.
    Sugita M; van Der Wel N; Rogers RA; Peters PJ; Brenner MB
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8445-50. PubMed ID: 10890914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species.
    Donovan MJ; Jayakumar A; McDowell MA
    Parasite Immunol; 2007 Oct; 29(10):515-24. PubMed ID: 17883454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.
    Coventry BJ; Austyn JM; Chryssidis S; Hankins D; Harris A
    Adv Exp Med Biol; 1997; 417():571-7. PubMed ID: 9286420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
    van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
    Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1a and antitumour immune response.
    La Rocca G; Anzalone R; Bucchieri F; Farina F; Cappello F; Zummo G
    Immunol Lett; 2004 Aug; 95(1):1-4. PubMed ID: 15325791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1 antigen presentation: how it works.
    Barral DC; Brenner MB
    Nat Rev Immunol; 2007 Dec; 7(12):929-41. PubMed ID: 18037897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1a in human cancers: a new role for an old molecule.
    Coventry B; Heinzel S
    Trends Immunol; 2004 May; 25(5):242-8. PubMed ID: 15099564
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.
    Gelin C; Sloma I; Charron D; Mooney N
    J Leukoc Biol; 2009 Feb; 85(2):215-24. PubMed ID: 18809734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia.
    Hayati AR; Zulkarnaen M
    Int J Gynecol Pathol; 2007 Jan; 26(1):83-8. PubMed ID: 17197902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
    Gervais A; Levêque J; Bouet-Toussaint F; Burtin F; Lesimple T; Sulpice L; Patard JJ; Genetet N; Catros-Quemener V
    Breast Cancer Res; 2005; 7(3):R326-35. PubMed ID: 15987427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the function of CD1-restricted T cells.
    Vincent MS; Gumperz JE; Brenner MB
    Nat Immunol; 2003 Jun; 4(6):517-23. PubMed ID: 12774075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1-dependent dendritic cell instruction.
    Vincent MS; Leslie DS; Gumperz JE; Xiong X; Grant EP; Brenner MB
    Nat Immunol; 2002 Dec; 3(12):1163-8. PubMed ID: 12415264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
    Ulrichs T; Porcelli SA
    Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.